These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19583841)

  • 1. Increased levels of active c-Src distinguish invasive from in situ lobular lesions.
    Zou D; Yoon HS; Anjomshoaa A; Perez D; Fukuzawa R; Guilford P; Humar B
    Breast Cancer Res; 2009; 11(4):R45. PubMed ID: 19583841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
    Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
    Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
    J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
    Aktas B; Tewes M; Fehm T; Hauch S; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R46. PubMed ID: 19589136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
    Nayar R; Zhuang Z; Merino MJ; Silverberg SG
    Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lobular neoplasms and invasive lobular breast cancer].
    Sinn HP; Helmchen B; Heil J; Aulmann S
    Pathologe; 2014 Feb; 35(1):45-53. PubMed ID: 24435155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
    Giricz O; Reynolds PA; Ramnauth A; Liu C; Wang T; Stead L; Childs G; Rohan T; Shapiro N; Fineberg S; Kenny PA; Loudig O
    J Pathol; 2012 Jan; 226(1):108-19. PubMed ID: 21953071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
    Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
    Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
    Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
    Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular drivers of lobular carcinoma in situ.
    Logan GJ; Dabbs DJ; Lucas PC; Jankowitz RC; Brown DD; Clark BZ; Oesterreich S; McAuliffe PF
    Breast Cancer Res; 2015 Jun; 17():76. PubMed ID: 26041550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
    Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
    Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
    Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
    AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy.
    Berg WA; Mrose HE; Ioffe OB
    Radiology; 2001 Feb; 218(2):503-9. PubMed ID: 11161169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy.
    Shin SJ; Rosen PP
    Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
    Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
    Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
    Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
    Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
    Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
    Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.